Are you Dr. Liu Dumlao?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2946 E Banner Gateway Dr
Suite 450
Gilbert, AZ 85234Phone+1 480-256-6444Fax+1 480-256-4683
Summary
- Dr. Theresa (Dumlao) Liu Dumlao, MD is an oncologist in Gilbert, Arizona. She is currently licensed to practice medicine in Arizona, Iowa, and Texas. She is affiliated with Banner Gateway Medical Center and Banner Baywood Medical Center.
Education & Training
One Brooklyn Health System/Brookdale University Hospital and Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1995 - 1998
Cebu Institute of MedicineClass of 1993
Certifications & Licensure
AZ State Medical License 2004 - 2025
FL State Medical License 1998 - 2025
IA State Medical License 2015 - 2025
SC State Medical License 2003 - 2025
TX State Medical License 2011 - 2025
AL State Medical License 2004 - 2024
IL State Medical License 1995 - 2002- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 6 citationsA Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.Theresa L. Werner, Abhijit Ray, John G. Lamb, Matthew W. VanBrocklin, Kristin Hueftle
Clinical Breast Cancer. 2017-11-01 - 1 citationsA phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors.Adam L Cohen, Abhijit Ray, Matthew Van Brocklin, David M Burnett, Randy C Bowen
Oncotarget. 2017-08-08 - 43 citationsPhase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemiaOhad Benjamini, Theresa Liu Dumlao, Hagop M. Kantarjian, Susan O'Brien, Guillermo Garcia-Manero
American Journal of Hematology. 2014-03-01
